GlassScriptPhysician profile
Veronica A Covalesky
NPI 1619947553
$1,547.82
in general payments reported to CMS, 2019-2025
19 companies · $625 in 2025
The $625 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $134 · 2020: $23.72 · 2023: $130 · 2024: $636 · 2025: $625.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,390.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,390.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ge Healthcare | $221.67 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $209.65 | 2024-2025 | |
| Novo Nordisk INC | $150.56 | 2024-2025 | Wegovy, Ozempic, Rybelsus |
| Amarin Pharma, INC. | $133.81 | 2019 | |
| Edwards Lifesciences Corporation | $131.14 | 2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| E.R. Squibb & Sons, L.L.C. | $130.01 | 2023 | Camzyos |
| Cleerly, INC. | $127.07 | 2025 | Cleerly Labs, Cleerly Ischemia |
| Astrazeneca Pharmaceuticals LP | $76.92 | 2025 | Wainua |
| Alnylam Pharmaceuticals INC. | $74.58 | 2025 | Onpattro |
| Canon Medical Systems USA, INC. | $58.23 | 2025 | Interventional Angiography System |
| Lilly USA, LLC | $43.81 | 2024-2025 | Mounjaro, Zepbound |
| Amgen INC. | $41.39 | 2025 | Repatha, Repatha |
| Kestra Medical Technology Services, INC. | $27.99 | 2025 | Assure Wcd |
| Boehringer Ingelheim Pharmaceuticals, INC. | $24.50 | 2024 | Jardiance |
| Janssen Pharmaceuticals, INC | $23.72 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $20.84 | 2024 | Nexletol |
| Pfizer INC. | $19.67 | 2025 | |
| Irhythm Technologies, INC. | $16.18 | 2024 | Zio Monitor, Zio Xt Patch |
| Medtronic, INC. | $16.08 | 2025 | Closurefast |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Veronica Covalesky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.